Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Journal of Hematology & Oncology|October 1, 2016
A synthetic three-dimensional niche system facilitates generation of functional hematopoietic cells from human-induced pluripotent stem cellsYulin Xu, Wei Shan, Xia Li, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 12, 2010
Immunosuppressive cytokine gene polymorphisms and outcome after related and unrelated hematopoietic cell transplantation in a chinese populationHaowen Xiao, Weijie Cao, Xiaoyu Lai, et al.
Annals of Hematology|May 21, 2025
Selective efficacy of venetoclax in unfit patients with acute myeloid leukemia with myelodysplasia-related gene mutations under low-intensity therapyJinya Lin, Xiupu Liu, Shuangwei Ying, et al.
Annals of Hematology|October 24, 2025
Developmental stage modulates the prognostic impact of RAS pathway mutations in AML patients undergoing Allo-HSCTXiaolin Yuan, Yibo Wu, Yanan Wang, et al.
Annals of Hematology|July 4, 2024
Impact of additional cytogenetic aberrations at diagnosis on prognosis of adults patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic hematopoietic cell transplantation: a retrospective analysisJing Zheng, Yanmin Zhao, Yi Luo, et al.
Cell Reports. Medicine|May 27, 2025
CD97-directed CAR-T cells with enhanced persistence eradicate acute myeloid leukemia in diverse xenograft modelsKai Shang, Deyu Huang, Jun Liu, et al.
Oncoimmunology|April 14, 2017
Combining therapeutic antibodies using basiliximab and etanercept for severe steroid-refractory acute graft-versus-host disease: A multi-center prospective studyYamin Tan, Haowen Xiao, Depei Wu, et al.
Annals of Hematology|January 22, 2025
Adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation and tyrosine kinase inhibitors: development and validation of a clinical prediction model based on cytogenetics, IKZF1 deletions and minimal residual diseaseJing Zheng, Yuping Zhou, Yanmin Zhao, et al.
Communications Biology|August 15, 2025
STRaM: A genetic framework for improved cell product provenance for research and clinical translationsBinglin Li, Chi Le, Wen Lei, et al.
Frontiers in Oncology|November 1, 2021
Non-Ablative Chemotherapy Followed by HLA-Mismatched Allogeneic CD3+ T-Cells Infusion Causes An Augment of T-Cells With Mild CRS: A Multi-Centers Single-Arm Prospective Study on Elderly Acute Myeloid Leukemia and int-2/High Risk Myelodysplastic Syndrome PatientsYan Huang, Minghua Hong, Zhigang Qu, et al.
Pageof 8